• Toggle Accessibility Statement
  • Home
  • Skip to Main Content
  • Sitemap
×
  • Transparency Seal
  • Corporate Governance
    • Corporate Governance Scorecard Report 2022
    • Corporate Governance Scorecard Report 2023
  • Procurement Opportunities
  • AUXILIARY MENU
  • About Us
    • The President and Chief Executive Officer
    • Board of the Directors
    • Corporate Officers
    • Organizational Structure
  • Our Pricelist
  • Our Programs
  • Career Opportunity
  • Contact Us
Menu
GOVPH
  • GOVPH
  • Transparency Seal
  • Corporate Governance
    • Corporate Governance Scorecard Report 2022
    • Corporate Governance Scorecard Report 2023
  • Procurement Opportunities
    • Accessibility Statement
    • High Contrast
    • Skip to Content
    • Skip to Footer
    • Default Text Size
    • Reduce Text Size - -
    • Enlarge Text Size + +

PHILIPPINE PHARMA PROCUREMENT INC Official Logo
Republic of the Philippines
PHILIPPINE PHARMA PROCUREMENT INC
ATTACHED AGENCY OF THE DEPARTMENT OF TRADE AND INDUSTRY

Philippine Standard Time:
Logo Gallery
Your Image
Your Image Your Image Your Image
  • About Us
    • The President and Chief Executive Officer
    • Board of the Directors
    • Corporate Officers
    • Organizational Structure
  • Our Pricelist
  • Our Programs
  • Career Opportunity
  • Contact Us

Corporate Governance

I. Institutional Matters
II. On the Board and Offices
III. On Financial and Operational Matters
IV. On Governance Matters
V. Corporate Social Resposibility
I. Institutional Matters
    1. PPPI Legal Basis

         

          1. SEC Certificate of Filing of Amended Articles of Incorporation (change of name and amending the primary and secondary purpose of the corporation)

          1. SEC Certificate of Amended By-Laws issued on 09 November 2005

          1. SEC Certificate of Filing of Amended Articles of Incorporation (increase in capitalization)

          1. SEC Certificate of Increase of Capital Stocks

          1. SEC Certificate of Filing of Amended Articles of Incorporation (change of name and amending the primary purpose of the corporation)

          1. SEC Certificate of Amended By-Laws issued on 26 November 2015

          1. Executive Order No. 649-A – transferring PPI to DOH from OP

          1. Executive Order No. 54 – transferring PPI to DTI from DOH

      1. Company background and SEC General Information Sheet

         

          • 2024
          • 2023
          • 2022

          • 2016

          • 2015

          • 2014

          • 2013

      1. Parent Company and Affiliate

    Philippine Pharma Procurement inc

     is a subsidiary of the

    and an affiliate of the

     

    4. Government Corporate Information Sheet (GCIS), as mandated by the GCG in its Memorandum Circular No. 2012 – 01

    • 2016
    • 2015
    • 2014
    • 2013
    II. On the Board and Offices
    1. Complete List of Directors and Officers
      • Governing Board
      • Corporate Officers
      • Key Officers
      • Organizational Chart
    2. The Complete compensation package of all board members and officers, including travel, representation and any other form of expenses of allowances
      • 2022-2024 ROSA
      • 2010 -2021 ROSA
    3. Information on Board Committees
    4. Attendance Record of Directors in Board Meetings
      • 2024
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
    III. On Financial and Operational Matters
    1. Annual Audit Reports (AARs)
      1. 2024
      2. 2023
      3. 2022
      4. 2021
      5. 2020
      6. 2019
      7. 2018
      8. 2017
      9. 2016
      10. 2015
      11. 2014
      12. 2013

    2. Quarterly Financial Reports and Trial Balance

    2024

    • 1st Quarter Financial Reports and Trial Balance
    • 2nd Quarter Financial Reports and Trial Balance

    2023

    • 1st Quarter 2023  Financial Reports and Trial Balance
    • 2nd Quarter 2023  Financial Reports and Trial Balance
    • 3rd Quarter 2023  Financial Reports and Trial Balance

    2022

    • 1st Quarter 2022  Financial Reports and Trial Balance
    • 2nd Quarter 2022  Financial Reports and Trial Balance
    • 3rd Quarter 2022 Financial Reports and Trial Balance

    3. Board Approved Corporate Operating Budget

    1. 2024
    2. 2023
    3. 2022
    4. 2021
    5. 2020
    6. 2019
    7. 2018
    8. 2017
    9. 2016
    10. 2015
    11. 2014
    1. Local and Foreign Borrowing(Not Applicable)

    1. Government Subsidies and Net Lending(Not Applicable)
    2. Borrowing Guaranteed by the Government(Not Applicable)
    3. Material Risk Factors and Measures to Manage Such Risk
    4. Performance Evaluation System
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013

     

    IV. On Governance Matters
    1. Charter Statement
    2. Strategy Map and 2024 Performance Scorecard
    3. Organizational Chart
    4. Manual of Corporate Governance
    5. Corporate Social Responsibility statement
    6. Balanced Scorecard
    7. No Gift Policy
    8. Code of Conduct for PPPI Officers and Employees
    9. Statement of No Audit Suspensions, Disallowances and Charges (SASDC)
      1. 2025
        • 4Q
        • 3Q
        • 2Q
        • 1Q
      2.  2024
        • 4Q
        • 3Q
        • 2Q
        • 1Q
      3.  2023
        • 1Q
        • 2Q
        • 3Q
        • 4Q
      4. 2022
        • 1Q
        • 2Q
        • 3Q
        • 4Q
      5. 2021
        • 2Q
        • 4Q
      6. 2020
        • 1Q
        • 2Q
        • 3Q
        • 4Q
      7. 2019
        • 2Q
        • 3Q
        • 4Q
      8. 2018
        • 1Q
        • 2Q
        • 3Q
      9. 2017
        • 1Q
        • 2Q
        • 3Q
        • 4Q

     

    j. Agency Action Plan and Status of Implementation on COA AOM

    • 2023
    • 2022
    • 2021
    • 2017
    • 2015

           h.Freedom of Information Manual

    V. Corporate Social Resposibility

      Employees’ Welfare and Development

    1. Training and Development Program
      1. 2019
      2. 2018
      3. 2017
      4. 2016
      5. 2015
    2. List of Training Conducted
      1. 2019
      2. 2018
      3. 2017
      4. 2016
      5. 2015